Results 141 to 150 of about 186,949 (193)

Tissue and Sex-Specific Performance of a Cancer Driver Based Biomarker in rasH2-Tg Mice. [PDF]

Environ Mol Mutagen
Harris KL, Faske JB, Gong B, Parsons BL.
europepmc   +1 more source

Feasibility of long-read sequencing to identify molecular alterations in an Indonesian cohort of locally advanced to advanced nasopharyngeal cancer. [PDF]

Sci Rep
Handoko, Adham M, Rachmadi L, Tobing DL, Asmarinah, Fadilah, Dai W, Lee AWM, Gondhowiardjo SA.   +8 more
europepmc   +1 more source

Assessment of 1863 <i>GRIN2A</i> Variants Contradicts a Role in Tumorigenesis. [PDF]

Int J Mol Sci
Jauss RT, Lemke JR, Strehlow V.
europepmc   +1 more source

TP53 c.730G > A pathogenic variant as a plausible candidate biomarker in pancreatic ductal adenocarcinoma patients from Karachi, pakistan: a retrospective cohort study. [PDF]

BMC Cancer
Ali SMA, Adnan Y, Ali SM, Ahmad Z, Azam I, Chawla T, Farooqui HA.   +6 more
europepmc   +1 more source

Heterozygous Germline Fanconi Anemia-Related Gene Mutations Increase Susceptibility to Germ Cell Tumors. [PDF]

JCO Precis Oncol
Wang J, Luo N, Han T, Yin X, Wang G.
europepmc   +1 more source

Using single-cell perturbation screens to decode the regulatory architecture of splicing factor programs. [PDF]

Nucleic Acids Res
Anglada-Girotto M, Miravet-Verde S, Serrano L.   +2 more
europepmc   +1 more source

Characterization of Mutational Signatures in Tumors from a Large Chinese Population. [PDF]

Cancer Res Commun
Chevalier A, Guo T, Gurevich NQ, Xu J, Yajima M, Campbell JD.   +5 more
europepmc   +1 more source

Refined variant calling pipeline on RNA-seq data of breast cancer cell lines without matched-normal samples. [PDF]

BMC Res Notes
Eberth S, Koblitz J, Steenpaß L, Pommerenke C.   +3 more
europepmc   +1 more source

Systemic inflammation biomarkers can identify high tumor mutation burden in lung adenocarcinoma. [PDF]

BMC Cancer
Fang J, Li Q, Xu N, Yang X, Zhang Q, Chen Y, Li H.   +6 more
europepmc   +1 more source